Your browser doesn't support javascript.
loading
Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
Xie, Daxing; Shen, Jie; Gong, Jianping.
Affiliation
  • Xie D; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Shen J; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Gong J; Department of Gastrointestinal Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Br J Surg ; 111(7)2024 Jul 02.
Article in En | MEDLINE | ID: mdl-38995921

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Randomized Controlled Trials as Topic / Gastrectomy / Lymph Node Excision Limits: Humans Language: En Journal: Br J Surg Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Randomized Controlled Trials as Topic / Gastrectomy / Lymph Node Excision Limits: Humans Language: En Journal: Br J Surg Year: 2024 Document type: Article Affiliation country: China